ResMed Inc. vs Ryanair Holdings plc — how do they compare? ResMed Inc. trades at $220 (market cap $32.61B), while Ryanair Holdings plc trades at $60.03 (market cap $29.63B). The key difference: ResMed Inc. and Ryanair Holdings plc are close in size by market cap, and Ryanair Holdings plc pays the higher dividend (1.51%). Which is the better fit depends on your goals.
| RMD | RYAAY | |
|---|---|---|
Market Cap | $32.61B | $29.63B |
Sector | Health | Industrials |
52-Week High | $293.73 | $73.82 |
52-Week Low | $182.82 | $53.24 |
Enterprise Value | $31.97B | $26.61B |
Dividend Yield | 1.17% | 1.51% |
Trailing returns across standard periods
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →Ryanair is the leading airline group by passenger numbers in Europe. The company employs a low-cost no-frills model to offer low fares to leisure customers on short-haul intra-European routes. In 2020, the most recent pre-pandemic fiscal year, the company carried 149 million passengers, utilizing a fleet of 467 Boeing 737 aircraft across its 1,800 routes. To keep costs low the company serves predominantly lower-cost secondary airports. The company generated sales of EUR 8.5 billion in fiscal 2020.
Read more on RYAAY →